The invention discloses and be used for the treatment of and/or prevent type 2 diabetes mellitus, insulin resistance and be characterised in that the morbid state of insulin resistance and the method for disease, obesity, hyperglycemia, hyperinsulinemia and type 1 diabetes, it comprises anti-il-i-beta antibody or its fragment of using effective dose to the experimenter.